Ad
Friday, 8 March 2019
OxyContin maker Purdue Pharma loses bid to delay opioid epidemic trial
OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a lawsuit by Oklahoma's attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment